A global study published in Nature Medicine has revealed the alarming health impacts of sugary drinks/sugar-sweetened beverages (SSBs), highlighting their contribution to the growing prevalence of Type 2 Diabetes (T2D) and Cardiovascular Disease (CVD) worldwide.
The research, conducted by the Global Dietary Database collaboration, analyzed data from 184 countries, including 450 dietary surveys representing 2.9 million individuals. Findings suggest that sugary drink consumption accounted for 2.2 million new diabetes cases and 1.2 million cardiovascular cases globally in 2020.
Key Regional Insights:
- Latin America and the Caribbean: The highest proportional burden, with 24.4% of diabetes and 11.3% of cardiovascular cases linked to SSB consumption.
- Sub-Saharan Africa: Experienced an 8.8% rise in diabetes burdens and a 4.4% rise in CVD cases between 1990 and 2020.
- United States and Mexico: Showed consistently high impacts, reflecting elevated consumption levels.
Researchers highlighted socioeconomic disparities, with lower education levels correlating with higher vulnerability to SSB-related health risks. Urban residents and younger populations showed higher consumption rates, intensifying disease prevalence in these groups.
Major Findings:
- 12.5 million global DALYs (Disability-Adjusted Life Years) were linked to sugary drink intake in 2020.
- 6.9% of diabetes-related DALYs and 3.0% of cardiovascular-related DALYs were directly attributable to sugary beverages.
- Direct sugar consumption and BMI-mediated pathways both contributed significantly to health risks.
The study emphasized that SSB consumption not only leads to obesity and impaired glucose metabolism but also directly impacts cardiovascular and metabolic health.
Targeted Solutions to Avoid Sugary Drinks:
Experts suggest implementing strategies such as:
- SSB taxes
- Front-of-package labeling
- Public health campaigns
- Education programs on sugar risks
Global disparities indicate the need for region-specific policies to address the rising burden, particularly in low- and middle-income countries like Sub-Saharan Africa, where consumption patterns are shifting rapidly.
The research underscores that reducing SSB intake is a critical step in combating the global epidemic of non-communicable diseases, advocating for immediate action to improve health outcomes and reduce healthcare costs globally.
More Information: Lara-Castor, L., O’Hearn, M., Cudhea, F., Miller, V., Shi, P., Zhang, J., Sharib, J. R., Cash, S. B., Barquera, S., Micha, R., Mozaffarian, & Global Dietary Database (2025). Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries. Nature Medicine. DOI:10.1038/s41591024033454, https://www.nature.com/articles/s41591-024-03345-4
more recommended stories
Digital Heart Twins Show Promise for AF Ablation PrecisionKey Summary Researchers developed patient-specific digital.
Li-Fraumeni Syndrome Surveillance Improves SurvivalKey Summary A Europe-wide study found.
Alzheimer’s Disease Study Questions Glucosamine SafetyKey Summary New research published in.
Women’s Healthcare Advances Through FemTechKey Summary FemTech has grown from.
WHO: Andes Hantavirus Not a COVID-19-Level ThreatKey Summary Andes hantavirus has drawn.
Mazdutide Shows Significant Weight Loss in Phase 3 TrialKey Summary Mazdutide, a dual GLP-1.
Genetic Screening Project Launches for Brazilian ParentsKey Summary Brazil is launching the.
Nasal Microbiome Associated With Better Mental Well-BeingKey Summary Researchers found that exposure.
Fatherhood Linked to Lower Mortality Risk in Black MenKey Summary A new longitudinal study.
CAR T-Cell Therapy Offers Hope for Highly Sensitized PatientsKey Summary Researchers at the University.

Leave a Comment